2020
DOI: 10.4103/ijo.ijo_883_20
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19: Ophthalmic prophylactic and therapeutic measures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…In case of conjunctivitis with COVID-19, this preparation may help to reduce the viral load due to its action against a wide range of viruses. Burning and irritation is a significant side effects of the drug, which can be effectively reduced by diluting 1 mL of 5% Betadine with 4 mL of Benzalkonium chloride (BAK) containing lubricant drops [77]. This formulation will have the advantage of dual antiviral action with BAK and Betadine with patient comfort [76][77][78].…”
Section: Pvp-i Formulations Have Been Previously Shown To Be Active A...mentioning
confidence: 99%
See 1 more Smart Citation
“…In case of conjunctivitis with COVID-19, this preparation may help to reduce the viral load due to its action against a wide range of viruses. Burning and irritation is a significant side effects of the drug, which can be effectively reduced by diluting 1 mL of 5% Betadine with 4 mL of Benzalkonium chloride (BAK) containing lubricant drops [77]. This formulation will have the advantage of dual antiviral action with BAK and Betadine with patient comfort [76][77][78].…”
Section: Pvp-i Formulations Have Been Previously Shown To Be Active A...mentioning
confidence: 99%
“…Burning and irritation is a significant side effects of the drug, which can be effectively reduced by diluting 1 mL of 5% Betadine with 4 mL of Benzalkonium chloride (BAK) containing lubricant drops [77]. This formulation will have the advantage of dual antiviral action with BAK and Betadine with patient comfort [76][77][78]. It can help in decreasing the risk for contamination due to accidental eye exposure or contact, at a remarkable level.…”
Section: Pvp-i Formulations Have Been Previously Shown To Be Active A...mentioning
confidence: 99%
“…In the study of the related therapeutic outlook in many diseases, the pharmacological features of certain natural products have acquired growing recognition [ 17 ]. In this way, the food industry is attempting to manufacture substances that concentrate on bioactive substances found in food or in natural ingredients that are often regarded as nutraceuticals, which, besides their nutritional qualities, can provide results based on health benefits, in particular in the management of chronic diseases [ 18 ].…”
Section: Introductionmentioning
confidence: 99%